Emanuele Sasso is a research fellow at the University of Naples Federico II (Italy). He has a PhD in molecular medicine and medical biotechnologies. He joined two biotech companies, developing monoclonal antibodies and cancer vaccines; and has authored 20 manuscripts, of which 8 were as the first or corresponding author. He is also the inventor of several granted and under-evaluation patents.